ABN Amro Investment Solutions Invests $14.06 Million in Colgate-Palmolive Company $CL

ABN Amro Investment Solutions bought a new position in shares of Colgate-Palmolive Company (NYSE:CLFree Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 154,662 shares of the company’s stock, valued at approximately $14,059,000.

A number of other institutional investors have also recently bought and sold shares of CL. Impax Asset Management Group plc grew its position in Colgate-Palmolive by 4.9% in the second quarter. Impax Asset Management Group plc now owns 251,640 shares of the company’s stock valued at $22,874,000 after purchasing an additional 11,790 shares in the last quarter. Police & Firemen s Retirement System of New Jersey raised its holdings in shares of Colgate-Palmolive by 3.5% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 122,082 shares of the company’s stock valued at $11,097,000 after purchasing an additional 4,109 shares during the period. Maple Capital Management Inc. raised its stake in Colgate-Palmolive by 15.7% in the second quarter. Maple Capital Management Inc. now owns 164,077 shares of the company’s stock valued at $14,915,000 after buying an additional 22,207 shares during the period. denkapparat Operations GmbH lifted its holdings in Colgate-Palmolive by 63.1% during the 2nd quarter. denkapparat Operations GmbH now owns 6,682 shares of the company’s stock valued at $607,000 after purchasing an additional 2,584 shares during the last quarter. Finally, Wealth Alliance LLC lifted its stake in shares of Colgate-Palmolive by 16.7% during the 2nd quarter. Wealth Alliance LLC now owns 4,838 shares of the company’s stock worth $440,000 after buying an additional 691 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on CL. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, October 8th. Citigroup reduced their price target on Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating on the stock in a research report on Monday, November 3rd. Barclays cut their target price on Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 4th. JPMorgan Chase & Co. decreased their price target on Colgate-Palmolive from $88.00 to $87.00 and set an “overweight” rating on the stock in a research report on Monday, November 3rd. Finally, Wells Fargo & Company cut their price objective on shares of Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating for the company in a research report on Monday, November 3rd. Nine equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus target price of $89.87.

Get Our Latest Stock Analysis on CL

Colgate-Palmolive Stock Performance

CL stock opened at $78.57 on Thursday. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The stock has a 50-day moving average price of $79.42 and a 200-day moving average price of $85.39. The firm has a market cap of $63.33 billion, a PE ratio of 22.07, a price-to-earnings-growth ratio of 4.44 and a beta of 0.35.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.17 billion. During the same quarter in the previous year, the business posted $0.91 EPS. Colgate-Palmolive’s revenue for the quarter was up 1.9% compared to the same quarter last year. As a group, equities research analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive’s payout ratio is currently 58.26%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.